News for Rockwell Medical, Inc. (RMTI)

We recently published a list of Thursday’s 10 Worst-Performing Stocks. In this article, we are going to take a look at where Rockwell Medical Inc.

Net Sales (Full Year 2024): $101.5 million, a 21% increase over 2023.Net Sales (Q4 2024): $24.7 million, a 12% increase over Q4 2023.Gross Margin (Full Year 20

Mar 20, 2025 / 12:00PM GMTOperator Good morning, and welcome to Rockwell Medical's fourth quarter and full year 2024 results conference call and webcast. Please

Rockwell Medical achieved record sales and profitability in 2024 but faces a key customer loss in 2025.

Rockwell Medical, Inc. (NASDAQ:RMTI) Q4 2024 Earnings Conference Call March 20, 2025 8:00 AM ETCompany ParticipantsHeather Hunter - Senior Vice President,...

Singapore-based Sag Holdings Inc (SAG) is up over 67 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodia

Quarterly Revenue: $24.7 million, surpassing the estimated $23.65 million and marking a 12% increase year-over-year.Annual Revenue: Achieved $101.5 million, ex

Rockwell Medical (RMTI) delivered earnings and revenue surprises of -200% and 9.09%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Rockwell Medical (RMTI) reports Q4 earnings March 20. Analysts project $0.02 EPS & $23.65M revenue.

Rockwell Medical, Inc. (the ”œCompany”) (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hem

Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodia

On December 31, 2024, ARMISTICE CAPITAL, LLC (Trades, Portfolio) executed a strategic transaction involving Rockwell Medical Inc (RMTI). The firm reduced its ho

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

Rockwell Medical secures major dialysis product deal; shares soar

Incumbent Board has Destroyed Stockholder Value and Imperiled AIM's Future through Breaches of Fiduciary Duty and Bad Faith Actions

Incumbent Board has Destroyed Stockholder Value and Imperiled AIM's Future through Breaches of Fiduciary Duty and Bad Faith Actions

Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodia

Jesse Neri has been promoted to Chief Financial Officer at Rockwell Medical, overseeing all aspects of the company's finance organization.